Work in progress - new look and feel RIVM website As of today, the RIVM website looks different than you are used to. This is because we are now using a new content management system and have implemented an enhanced design.
New data on antimicrobial resistance in European countries New data on antimicrobial resistance (AMR) in European countries is now available in the fourth annual report of the Central Asian and Eastern European Surveillance of Antimicrobial Resistance (CAE
Framework Agreement signed between INERIS and RIVM to strengthen cooperation On 7 November 2018, Raymond Cointe, Director-General of INERIS and Hans Brug, Director-General of RIVM, signed a Framework Agreement. RIVM has been working with the French National Institute f
Public Health Foresight study 2018 now available in English The prospects for future public health in the Netherlands are good. Our life expectancy is steadily increasing, and most people feel healthy and do not experience activity limitations.
Coen van Gool named co-chair of WHO Family Development Committee Coen van Gool was named co-chair of the Family Development Committee (FDC) at the Annual Meeting 2018 of the WHO Family of International Classifications (WHO-FIC) Network in Seoul.
Changed indicative magnetic field zones around overhead high-voltage lines RIVM has updated the 2005 grid map (Netkaart) showing the overhead high-voltage lines in the Netherlands.
INHERIT Model: a tool to jointly improve health, environmental sustainability and Health Equity RIVM is involved in the Horizon2020 project INHERIT. The first article of the INHERIT project has been published, lead-authored by RIVM.
RIVM on shortlist Best Government Organisation of the Year 2018 The National Institute for Public Health and the Environment (RIVM) has made the shortlist for the 2018 election for best government organisation of the year.
RIVM supports WHO in national capacity building for measuring foodborne disease burden RIVM’s Collaborating Centre for Risk Assessment of Pathogens in Food and Water was invited to WHO’s side event during the 41st Codex Alimentarius Commission on July 4th 2018.
Rapid developments in modern biotechnology are a challenge for risk assessment Due to developments in modern biotechnology, such as genome editing, synthetic biology and regulation of gene expression, many new applications are expected in the next ten years.